LONDON: Pfizer and AstraZeneca coronavirus vaccines are effective against the variant identified in India after two doses, according to a study.
Two jabs of either vaccine give a similar level of protection against symptomatic disease from the Indian variant as they do for the Kent one, BBC said.
The vaccines were only 33 percent effective against the Indian variant three weeks after the first dose, it added.
And Public Health England, which conducted the study, said that the vaccines are likely to be more effective at preventing hospital admission and deaths.
According to the BBC report, the Pfizer vaccine was found to be 88 percent effective at stopping symptomatic disease from the Indian variant two weeks after the second dose, compared with 93 percent effectiveness against the Kent variant.
Likewise, while the AstraZeneca jab was 60 percent effective against the Indian variant, compared with 66 percent against the Kent variant.
(With inputs from BBC)
Comment